Patients with obesity and patients with colorectal cancer of poor differentiation, lymph node metastasis, advanced TNM stage, MSI, KRAS, BRAF or PIK3CA mutations had shorter overall survival. The gene discussed is KRAS; the disease is metastatic malignant neoplasm in the lymph nodes.